Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Martin

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Current Opinion in Immunology|October 3, 2006
When T cells recognize a pattern, they might cause troubleMireia Sospedra, Roland Martin
Seminars in Neurology|August 2, 2003
Future immunotherapies in multiple sclerosisGregg Blevins, Roland Martin
Expert Opinion on Investigational Drugs|October 25, 2013
Antigen-specific tolerization approaches in multiple sclerosisAndreas Lutterotti, Roland Martin
The Lancet. Neurology|May 20, 2008
Getting specific: monoclonal antibodies in multiple sclerosisAndreas Lutterotti, Roland Martin
Autoimmunity|February 4, 2006
Molecular mimicry in multiple sclerosisMireia Sospedra, Roland Martin
Handbook of Clinical Neurology|February 11, 2014
The good and the bad of neuroinflammation in multiple sclerosisMatthias Naegele, Roland Martin
Journal of the Neurological Sciences|July 9, 2004
A plea for "omics" research in complex diseases such as multiple sclerosis--a change of mind is neededRoland Martin, David Leppert
Nature Medicine|March 9, 2010
New drugs may improve, complicate treatment for multiple sclerosisHans Link, Roland Martin
Experimental Neurology|April 29, 2014
Daclizumab (anti-CD25) in multiple sclerosisNikolai Pfender, Roland Martin
Journal of Rehabilitation Research and Development|June 8, 2002
The immunopathogenesis of multiple sclerosisElisabetta Prat, Roland Martin
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Current Opinion in Immunology|October 3, 2006
When T cells recognize a pattern, they might cause troubleMireia Sospedra, Roland Martin
Seminars in Neurology|August 2, 2003
Future immunotherapies in multiple sclerosisGregg Blevins, Roland Martin
Expert Opinion on Investigational Drugs|October 25, 2013
Antigen-specific tolerization approaches in multiple sclerosisAndreas Lutterotti, Roland Martin
The Lancet. Neurology|May 20, 2008
Getting specific: monoclonal antibodies in multiple sclerosisAndreas Lutterotti, Roland Martin
Autoimmunity|February 4, 2006
Molecular mimicry in multiple sclerosisMireia Sospedra, Roland Martin
Handbook of Clinical Neurology|February 11, 2014
The good and the bad of neuroinflammation in multiple sclerosisMatthias Naegele, Roland Martin
Journal of the Neurological Sciences|July 9, 2004
A plea for "omics" research in complex diseases such as multiple sclerosis--a change of mind is neededRoland Martin, David Leppert
Nature Medicine|March 9, 2010
New drugs may improve, complicate treatment for multiple sclerosisHans Link, Roland Martin
Experimental Neurology|April 29, 2014
Daclizumab (anti-CD25) in multiple sclerosisNikolai Pfender, Roland Martin
Journal of Rehabilitation Research and Development|June 8, 2002
The immunopathogenesis of multiple sclerosisElisabetta Prat, Roland Martin
Pageof 22